The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.
about
Prevalence of ultrasonography proved polycystic ovaries in North Indian women with type 2 diabetes mellitusScreening for metabolic and reproductive complications in obese children and adolescentsOvarian aging in women with diabetes: An overview.Role of haptoglobin in polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women.Association of polymorphisms of interleukin-18 gene promoter region with polycystic ovary syndrome in chinese population.Is interleukin-18 associated with polycystic ovary syndrome?Polycystic ovary syndrome: not ovarian, not simple, unkind.Epidemiology, diagnosis, and management of polycystic ovary syndromeThe contentious nature of gestational diabetes: diet, insulin, glyburide and metformin.The pathophysiology of polycystic ovary syndrome.Diamel therapy in polycystic ovary syndrome reduces hyperinsulinaemia, insulin resistance, and hyperandrogenaemiaThe metabolic syndrome in polycystic ovary syndrome.Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age.Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes.Patterns of LHbetacf among women in health and disease.Impact of obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines.The prevalence of polycystic ovary syndrome in women with idiopathic intracranial hypertension.Identification of polycystic ovary syndrome potential drug targets based on pathobiological similarity in the protein-protein interaction network.Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?Glucose intolerance states in women with the polycystic ovary syndrome.Polycystic ovary syndrome and insulin: our understanding in the past, present and future.Inositol's and other nutraceuticals' synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives.Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects.The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.Tissue insulin sensitivity and body weight in polycystic ovary syndrome.Treatment of polycystic ovary syndrome with insulin-lowering agents.The prevalence of polycystic ovaries in Chinese women with a history of gestational diabetes mellitus.The prevalence of polycystic ovaries in women with a history of gestational diabetes.Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians
P2860
Q24814980-73AF5087-D5C5-48E1-844B-E835BE9146B9Q27012812-D9E55107-5701-4E21-9B26-A40C49A30141Q30239872-FB6687F6-3411-4734-948A-8CBB27E4CCA0Q33445558-DA6B1541-A227-4C22-85F5-2C4AD1460FC0Q34273781-CF21E278-AC13-4842-838E-8026C7072009Q34560258-564AB956-51FC-4D39-AC00-6F28B66DC4BFQ34565871-CCD1DA63-2C66-464B-A6E7-C036EFBA19CAQ34658641-578A7EA8-019B-454D-97C9-55B681506F58Q35000949-65EF4F65-A090-4A8C-9480-CAC546902C2AQ35608887-D9CEF0F5-CD92-4A09-BA1A-BE6923195879Q36072462-A840EB2E-FF7F-48BF-A139-2383B4FC8C44Q36472269-374FB587-2665-4C65-8A15-49FD0CEB36BDQ36739198-59F26A76-63A2-4DF8-8DAD-8A05F8EFEB96Q36920069-F84FB709-B1F4-4312-BE88-9AFF1100EBABQ36943172-1E34E8DF-CFCD-4ECC-94C2-A388923586C1Q37020199-1C72E50A-414D-482F-8E6E-F991912993DFQ37288278-74687607-E9D1-46B4-ACA2-650E90C7AF46Q37437344-AD81515E-B8BC-4411-BEEA-36E343BC861EQ37764078-9FDE5EF1-46C6-456E-A154-DB58D8B9CC08Q38150697-EBB17A2F-A668-4FBD-B2B1-B5C32DFC35FEQ38380065-980870E0-178A-48BC-8E1D-22B6180B5CE9Q38901819-DB118BE7-9396-4A52-8BAD-3E88B037BC0BQ39277927-1ACA117B-682E-440F-A103-E047D89481E2Q41640666-FC62421E-9394-4D4E-9F8C-1BD0A418BD82Q43725577-92AB470E-C13E-4B29-AD95-F64BE212D67AQ44084386-5CF39683-F82F-42A3-A072-BD98931F906CQ51486636-C64851A1-9614-426F-B98D-0AC44460922AQ51553418-8EB23035-D279-4FCB-BB3B-FA0E1A3E5461Q57414617-BCB7F671-7352-42BA-849D-0766F3D24993
P2860
The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.
@en
The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.
@nl
type
label
The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.
@en
The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.
@nl
prefLabel
The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.
@en
The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.
@nl
P2093
P2860
P1476
The prevalence of polycystic ovaries in women with type 2 diabetes mellitus.
@en
P2093
P2860
P356
10.1046/J.1365-2265.2000.00884.X
P577
2000-01-01T00:00:00Z